Physician profile
James M Corder
NPI 1073553897
$4,007.51
in general payments reported to CMS, 2019-2025
9 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.39 · 2020: $70.71 · 2021: $58.71 · 2022: $40.02 · 2024: $3,688 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,918 · Food and Beverage: $470 · Travel and Lodging: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,917.90 |
| Food and Beverage | $470.26 |
| Travel and Lodging | $435.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,569.63 | 2024 | |
| Haemonetics Corporation | $141.56 | 2022-2024 | Teg6s Hemostasis System |
| Grifols Shared Services North America, INC. | $135.63 | 2025 | |
| Edwards Lifesciences Corporation | $41.38 | 2020 | |
| Biogen, INC. | $37.13 | 2021 | |
| Davol INC. | $29.33 | 2020 | |
| Zimmer Biomet Holdings, INC. | $21.58 | 2021 | |
| Ethicon US, LLC | $16.88 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Corder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.